Vascular Intervention Devices
•14 stocks
•
Total Market Cap: Loading...
Market Cap Distribution
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (14)
%
| Company | Market Cap | Price |
|---|---|---|
|
Extends into vascular/interventional devices (IVL, DCB, IVUS) such as Bolt Medical, AGENT DCB, and TIVUS-related systems.
|
$141.15B |
$95.41
-1.94%
|
|
Vascular Intervention Devices - peripheral vascular and endovascular devices (e.g., thrombectomy systems via Inari acquisition).
|
$139.34B |
$364.60
-1.54%
|
|
Transcatheter repair/replacement devices and associated endovascular technologies align with Vascular Intervention Devices.
|
$43.37B |
$73.94
-1.58%
|
|
Penumbra's core products are endovascular vascular intervention devices (thrombectomy systems, catheters, and embolization coils).
|
$10.09B |
$260.49
+0.14%
|
|
BIOTRONIK vascular-intervention portfolio (DCBs, stents, Papyrus, Freesolve, etc.) constitutes a distinct endovascular interventional device category.
|
$5.28B |
$119.42
-4.53%
|
|
Wrappersody vascular endoprosthesis and related vascular intervention devices are core Merit Medical products.
|
$4.67B |
$78.99
-3.99%
|
|
Serves vascular and neurovascular device categories with its manufacturing capabilities.
|
$3.53B |
$101.05
-1.93%
|
|
VASCADE MVP XL and SavvyWire are interventional/vascular devices used in EP procedures and LAAC.
|
$2.35B |
$48.85
-2.81%
|
|
Core product category; Delcath's hepatic delivery system falls under vascular intervention devices used for targeted liver therapies.
|
$374.21M |
$10.74
-0.78%
|
|
Vascular Intervention Devices category covers endovascular/devices used in vascular reconstruction and related applications (e.g., pericardial/vascular patches).
|
$36.18M |
$0.89
+1.02%
|
|
PortIO IO intraosseous vascular access device is a vascular intervention device.
|
$8.61M |
$0.49
-13.83%
|
|
Vascular/interventional catheter-based devices: aligns with BioCardia's delivery systems for intracardiac therapy.
|
$7.04M |
$1.36
+0.37%
|
|
Platform is a catheter-based endovascular system designed to interact with peripheral nerves via the vascular system for targeted therapy.
|
$3.39M |
$1.26
-5.97%
|
|
Acquired pericardial access and related assets sit within vascular/interventional device categories.
|
$1.60M |
$2.76
-2.82%
|
Loading industry metrics...
Loading comparison data...
